for a subset of patients with kaposi 's sarcoma who were treated with recombinant interferon alfa-2a , the disease is in complete remission , without opportunistic infection , and they appear to be culture-negative for the etiologic retrovirus that causes their immune deficiency .
C0036220
kaposi 's sarcoma
C0021734
recombinant interferon alfa-2a